Novartis already has Aimovig (erenumab) approved in Europe, along with Eli Lilly’s Emgality (galcanezumab), with both drugs available as monthly injections. With Ajovy, which is also from the ...

They include: Aimovig, Ajovy, and Emgality are taken via subcutaneous injection. This means they're injected via a shot with a thin needle into fatty tissue (rather than deep into muscle).

Ajovy is used for the prevention of both episodic and chronic migraine. It is given by subcutaneous injection. It is self-administered once a month or in a higher dose every three months.

NICE has backed Emgality (galcanezumab) as a once-monthly injection to prevent migraine ... That puts Emgality ahead of Teva’s Ajovy (fremanezumab), which picked up a positive opinion from ...